THORELL MARELLA (Chief Financial Officer) sold 18.5% of their position (4K shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $1.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/3/2023ACC: 0001694665-23-000167
Officer· Chief Financial Officer
Since Jul 2022
-4K
Net shares
Net seller
$1.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.50K acquired · 16.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
137.8%
11/1/2023
9.07K→21.57K
Common Stock
Direct
Shares
−4K
Price / share
$0.33
Trade value
$1.32K
% of position
18.5%
11/2/2023
21.57K→17.57K
Total
Net shares
+8.50K
Net value
-$1.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/1/2023 | M · Option Exercise | +12.50K | — | — | 137.8% | 9.07K | 21.57K |
| Common Stock Direct | 11/2/2023 | S · Sale | −4K | $0.33 | $1.32K | 18.5% | 21.57K | 17.57K |
| Total | +8.50K | -$1.32K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
12.50K shares
Shares
−12.50K
Strike price
Held after
25K
Exercisable
—
11/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock12.50K shares | 11/1/2023 | M · Option Exercise | −12.50K | — | 25K |